The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot ...

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, has secured a new round of equity financing and announced additional milestones since the start of ...

The Accelerate NC Coalition is a statewide partnership dedicated to strengthening North Carolina’s life sciences ...

Durham-based Eboo Pharmaceuticals Inc. (EPI) is one of three U.S. biopharmaceutical companies selected by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) for its Partnering Program. The ...

Novo Nordisk has officially begun building a $1.8 billion production facility for diabetes medicines at its Clayton site that will create 700 high-paying jobs, doubling its workforce there. The ...

Locus Biosciences is a fast-emerging North Carolina biotechnology company that’s about to get a lot faster at unfolding its Pac-Man-like genetic tricks to whack drug-resistant bacteria. The Research ...

Candidates must possess a 4-year life science-related degree and 2 years of professional experience working for a life sciences-related company. If the minimum qualifications are met, an invitation to ...

GLAS, a Winston-Salem company that provides human biospecimens and consulting services to medical researchers, has been acquired by Precision for Medicine of Bethesda, Md. Terms of the deal were not ...

AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs.